4//SEC Filing
Ramelmeier Rolf Andrew 4
Accession 0001209191-21-015522
CIK 0001001233other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 9:11 PM ET
Size
10.8 KB
Accession
0001209191-21-015522
Insider Transaction Report
Form 4
Ramelmeier Rolf Andrew
EVP, Technical Operations
Transactions
- Award
Common Stock
2021-02-25+40,000→ 98,199 total - Tax Payment
Common Stock
2021-02-25$11.19/sh−7,779$87,047→ 58,199 total - Award
Stock Option (Right to Buy)
2021-02-25+80,000→ 80,000 totalExercise: $11.19Exp: 2031-02-24→ Common Stock (80,000 underlying)
Footnotes (4)
- [F1]Represents shares underlying the portions of restricted stock units ("RSUs") that vested on February 25, 2021 which were surrendered by the Reporting Person to the Issuer for tax withholding, using the Issuer's closing stock price on February 25, 2021 of $11.19/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP, as amended").
- [F2]Includes: (a) 2,726 shares resulting from the February 25, 2021 vesting of the Reporting Person's February 25, 2019 RSU grant and 4,167 shares subject to such RSU grant that will vest in one final annual installment on February 25, 2022; and (b) 11,993 shares resulting from the February 25, 2021 vesting of the Reporting Person's February 25, 2020 RSU grant and 36,668 shares subject to such RSU grant that will vest in two remaining annual installments of 18,331 shares and 18,337 shares on February 25, 2022 and 2023 respectively. The vesting of all such RSUs is subject to the Reporting Person's continued service as defined in the 2018 EIP, as amended, through such dates and subject to acceleration as defined in the 2018 EIP, as amended.
- [F3]Represents 40,000 shares of common stock issuable upon settlement of RSUs granted to the Reporting Person on February 25, 2021 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's Continuous Service as defined in the 2018 EIP, as amended, through such dates and subject to acceleration as defined in the 2018 EIP, as amended.
- [F4]One-quarter (1/4) of the option shares vest and become exercisable upon completion of one (1) year of Continuous Service, as defined in the 2018 EIP, as amended, by the Reporting Person measured from the February 25, 2021 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, subject to the Reporting Person's Continuous Service as defined in the 2018 EIP, as amended, through each such vesting date, and subject to acceleration as provided in the 2018 EIP, as amended.
Documents
Issuer
SANGAMO THERAPEUTICS, INC
CIK 0001001233
Entity typeother
Related Parties
1- filerCIK 0001789340
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 9:11 PM ET
- Size
- 10.8 KB